(VNRX)
ASE – Real vaqt narxi. Valyuta: USD
0.20
+0.00 (1.87%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.19
-0.00 (-1.98%)
Bozordan keyin: Mar 27, 2026, 7:58 PM EDT

ASE – Real vaqt narxi. Valyuta: USD
0.20
+0.00 (1.87%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.19
-0.00 (-1.98%)
Bozordan keyin: Mar 27, 2026, 7:58 PM EDT
VolitionRx Limited, ko'p millatli epigenetika kompaniyasi, Qo'shma Shtatlar, Yevropa va Osiyoda saratonning bir qator turlarini va NETosis bilan bog'liq kasalliklarni aniqlash va kuzatishga yordam beradigan qon testlarini ishlab chiqadi. Kompaniya itlar va boshqa hayvonlar uchun saratonni skrining qilish testi bo'lgan Nu.Q Vet; sepsis kabi NETosis bilan bog'liq kasalliklarni aniqlaydigan Nu.Q Nets; nukleosomlarni profiling qilish uchun yechim bo'lgan Nu.Q Discover; davolanishga javobni bashorat qilish, davolanishga javobni va kasallikning rivojlanishini kuzatish va bemorning saraton davolash rejimini o'zgartirish uchun Nu.Q Cancer; va plazma namunalari orqali saratonni erta aniqlash uchun saraton hujayralaridan olingan DNKni ajratish va tutib olish uchun Capture-PCR va Capture-Seqni taklif etadi. VolitionRx Limited Xenderson, Nevada shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Gaetan Michel Ph.D. | Chief Operating Officer |
| Dr. Jacob Vincent Micallef MBA, Ph.D. | Chief Scientific Officer |
| Dr. Jasmine Kway Ph.D. | Chief Executive Officer of Singapore Volition |
| Mr. Cameron Reynolds MBA | Founder, CEO, President & Director |
| Mr. Gael Forterre M.B.A. | Chief Commercial Officer |
| Mr. Nicholas Plummer | Group General Counsel |
| Mr. Rodney Gerard Rootsaert LLB | Corporate Secretary |
| Mr. Terig Hughes | CFO & Treasurer |
| Ms. Louise Batchelor Day | Group Chief Marketing & Communications Officer |
| Ms. Sharon Ballesteros | U.S. Head of Quality & Development Process |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-28 | D/A | |
| 2026-01-26 | PRE 14A | vnrx_pre14a.htm |
| 2026-01-08 | 8-K | vnrx_8k.htm |
| 2025-12-11 | 8-K | vnrx_8k.htm |
| 2025-11-13 | 8-K/A | vnrx_8ka.htm |
| 2025-11-10 | 8-K/A | vnrx_8ka.htm |
| 2025-11-07 | 8-K | vnrx_8k.htm |
| 2025-10-14 | 8-K | vnrx_8k.htm |
| 2025-08-15 | 10-Q/A | vnrx_10qa.htm |
| 2025-08-14 | 8-K | vnrx_8k.htm |